Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes

University of Minnesota (UMN)

Status

Completed

Conditions

Stress Disorder

Anxiety Disorder/Anxiety State

Drinking to Cope

Hypothalamic Pituitary Adrenal

Alcohol Use Disorder

Study type

Observational

Funder types

Other

NIH

Identifiers

NCT03056872

PSYCH-2017-23713

1K01AA024805 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Alcohol dependence is among the most common and costly public health problems affecting the nation. Among individuals with alcohol use disorder (AUD), those with (vs. without) a co-occurring anxiety disorder (AnxD) are as much as twice as likely to relapse in the months following AUD treatment. Dysregulation of biological stress-mood systems predict and correlate with AUD relapse and AnxD symptomatology. In contrast, stress system re-regulation correlates with improved AUD treatment outcomes but has not been examined with respect to AUD recovery and relapse in co-occurring AUD+AnxD.

Full description

The objectives of the proposed research are to 1) evaluate the effect of co-occurring AnxD on the severity of biological stress-mood system dysregulations in AUD inpatients at pre-treatment, 2) evaluate the effect of co-occurring AnxD on the persistence of stress-mood system dysregulations in AUD inpatients in the months following treatment, 3) evaluate the effects of treatment on biological stress-mood system re-regulation among AUD patients with co-occurring AnxD, and 4) evaluate the effect of re-regulation change in biological stress-mood system function on AUD clinical outcomes.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Ability to provide informed consent
Between the ages of 18 and 65
Diagnostic and Statistical Manual diagnosis of a Panic Disorder, Generalized Anxiety Disorder, or Social Anxiety Disorder within the past 30 days (AUD+AnxD group only).
Primary alcohol use disorder diagnosis and alcohol use in the 30 days preceding the study (AUD alone and AUD+AnxD groups only).
Inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug with nicotine accepted) dependence (AUD alone and AUD+AnxD groups only).
A minimum of a sixth-grade reading level.
Healthy controls, same criteria absent AUD and AnxD diagnosis of an alcohol and/or anxiety disorder
Lives within proximity to the Twin Cities (e.g., within about an hour's drive) or willing to drive to Fairview for the purpose of attending follow-up visits
Willingness to provide contact information to confirm follow-up appointments

Exclusion criteria

Lifetime history of psychosis or mania
Cognitive impairment, physical impairment, or chronic medical illness that precludes study participation
Primary PTSD as determined by qualifying assessment
Females currently pregnant
Exposure to antipsychotic medication for a total duration >16 weeks.
Prior head injury leading to >30 minutes of unconsciousness.
Cognitive impairment that impedes study participation.
Healthy controls with a history of any major medical or psychiatric disorders (e.g., schizophrenia, depression, heart disease, or stroke).
Suicide intent or attempt in the past 30 days
Cardiovascular health issues
Thyroid Disease
History of severe neurological illness such as chronic seizure disorder (e.g, epilepsy) or stroke
Brain tumor and/or implants in the skull cavity (e.g., plate in the skull)
Pacemaker